Allworth Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
VPM
VCM
EC
Allworth Financial's JAZZ Position: Q1 2026 in Review
Allworth Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 1,848% in Q1 2026, buying an estimated $74.3K and bringing the position to 448 shares worth $84.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1944.
Allworth Financial first reported a position in JAZZ in Q1 2019 and has held it in 25 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Allworth Financial held 448 shares of Jazz Pharmaceuticals worth $84.7K as of Q1 2026.
- Allworth Financial bought 425 Jazz Pharmaceuticals shares in Q1 2026, an estimated $74.3K.
- Jazz Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #1944 holding.
- Allworth Financial first reported a position in Jazz Pharmaceuticals in Q1 2019 and has held it in 25 quarters since.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.